K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the LungRobert J.C. Slebos, Sjoerd Rodenhuis, Jacob Stam et al.|New England Journal of Medicine|1990Cited by 811
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvementSjoerd Rodenhuis, Emiel J. Rutgers, Dick J. Richel et al.|The Lancet|1998Cited by 243